Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$371M |
| 2 |
FedEx
FDX
|
$339M |
| 3 |
UnitedHealth
UNH
|
$303M |
| 4 |
Charles Schwab
SCHW
|
$225M |
| 5 |
Baidu
BIDU
|
$214M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
$1.01B |
| 2 |
AstraZeneca
AZN
|
$542M |
| 3 |
Johnson Controls International
JCI
|
$386M |
| 4 |
Capital One
COF
|
$201M |
| 5 |
TE Connectivity
TEL
|
$169M |
Sector Composition
| 1 | Financials | 25.13% |
| 2 | Healthcare | 18.68% |
| 3 | Technology | 14.5% |
| 4 | Communication Services | 13.82% |
| 5 | Energy | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
GSK
GSK
$79.9B
| $2.18B | 1.67% | 46,388,219 -1,946,175 | -4% | -$91.5M |
|
27
Hewlett Packard
HPE
$29.6B
| $2.01B | 1.54% | 126,581,925 -9,962,708 | -7% | -$158M |
|
|
28
JPMorgan Chase
JPM
$829B
| $1.96B | 1.5% | 14,065,693 -7,250,217 | -34% | -$1.01B |
|
29
Baker Hughes
BKR
$44.8B
| $1.96B | 1.5% | 76,314,466 -588,484 | -0.8% | -$15.1M |
|
|
30
AstraZeneca
AZN
$248B
| $1.92B | 1.47% | 38,474,930 -10,874,210 | -22% | -$542M |
|
31
UBS Group
UBS
$128B
| $1.83B | 1.4% | 145,259,827 +261,000 | +0.2% | +$3.29M |
|
32
American Express
AXP
$231B
| $1.76B | 1.35% | 14,143,501 -395,897 | -3% | -$49.3M |
|
33
CVS Health
CVS
$92.8B
| $1.52B | 1.17% | 20,495,571 -357,601 | -2% | -$26.6M |
|
34
Truist Financial
TFC
$60.4B
| $1.47B | 1.13% | 26,102,026 +1,593,510 | +7% | +$89.7M |
|
35
APA Corp
APA
$8.31B
| $1.41B | 1.08% | 55,089,363 -315,384 | -0.6% | -$8.07M |
|
36
Celanese
CE
$5.22B
| $1.29B | 0.99% | 10,510,285 -309,045 | -3% | -$38M |
|
|
37
Baidu
BIDU
$32.8B
| $1.27B | 0.97% | 10,051,987 +1,695,800 | +20% | +$214M |
|
38
Suncor Energy
SU
$50.1B
| $1.25B | 0.95% | 38,023,000 +7,500 | +0% | +$246K |
|
39
Dell
DELL
$82.6B
| $1.24B | 0.95% | 24,139,365 +213,110 | +0.9% | +$11M |
|
|
JNPR
40
DELISTED
Juniper Networks
JNPR
| $1.21B | 0.93% | 49,167,696 -60,550 | -0.1% | -$1.49M |
|
41
Gilead Sciences
GILD
$140B
| $1.13B | 0.87% | 17,452,273 +15,752 | +0.1% | +$1.02M |
|
42
Halliburton
HAL
$19.4B
| $1.11B | 0.85% | 45,291,595 -388,975 | -0.9% | -$9.52M |
|
43
Fox Class A
FOXA
$26.6B
| $1.09B | 0.83% | 29,349,604 -35,063 | -0.1% | -$1.3M |
|
44
Eli Lilly
LLY
$657B
| $1.06B | 0.81% | 8,088,058 -730,995 | -8% | -$96.1M |
|
45
Cognizant
CTSH
$35.3B
| $1.06B | 0.81% | 17,113,758 -79,101 | -0.5% | -$4.91M |
|
|
DISH
46
DELISTED
DISH Network Corp.
DISH
| $1.04B | 0.8% | 29,281,228 -140,845 | -0.5% | -$5M |
|
|
HES
47
DELISTED
Hess
HES
| $986M | 0.75% | 14,755,034 +13,466 | +0.1% | +$900K |
|
48
Cisco
CSCO
$274B
| $978M | 0.75% | 20,401,184 -307,860 | -1% | -$14.8M |
|
49
Linde
LIN
$224B
| $939M | 0.72% | 4,374,194 -117,400 | -3% | -$25.2M |
|
|
CXO
50
DELISTED
CONCHO RESOURCES INC.
CXO
| $925M | 0.71% | 10,562,515 -11,662 | -0.1% | -$1.02M |
|